Ontology highlight
ABSTRACT: Purpose
To develop a universal gene therapy to overcome the genetic heterogeneity in retinitis pigmentosa (RP) resulting from mutations in rhodopsin (RHO).Design
Experimental study for a combination gene therapy that uses both gene ablation and gene replacement.Participants
This study included 2 kinds of human RHO mutation knock-in mouse models: RhoP23H and RhoD190N. In total, 23 RhoP23H/P23H, 43 RhoP23H/+, and 31 RhoD190N/+ mice were used for analysis.Methods
This study involved gene therapy using dual adeno-associated viruses (AAVs) that (1) destroy expression of the endogenous Rho gene in a mutation-independent manner via an improved clustered regularly interspaced short palindromic repeats-based gene
SUBMITTER: Tsai YT
PROVIDER: S-EPMC6109419 | biostudies-literature | 2018 Sep
REPOSITORIES: biostudies-literature